Prognostic impact of para-aortic lymph node metastasis in pancreatic ductal adenocarcinoma

World Journal of Surgery

Volumn 34, Issue 8, 2010, Pages 1900-1907

  Murakami, Yoshiaki ^a   Uemura, Kenichiro ^a   Sudo, Takeshi ^a   Hashimoto, Yasushi ^a   Yuasa, Yoshio ^a   Sueda, Taijiro ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CHI SQUARE DISTRIBUTION; FEMALE; HUMAN; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MALE; MIDDLE AGED; PANCREAS CARCINOMA; PANCREAS TUMOR; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SURVIVAL RATE;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, PANCREATIC DUCTAL; CHEMOTHERAPY, ADJUVANT; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 77955471956     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-010-0577-2     Document Type: Article

References (30)

1. A Jemal R Siegel E Ward, et al. 2008 Cancer statistics, 2008 CA Cancer J Clin 58 71 96 10.3322/CA.2007.0010 18287387 (Pubitemid 351521864)
2. HP Tan J Smith CA Garberoglio 1996 Pancreatic adenocarcinoma: an update J Am Coll Surg 183 164 184 1:STN:280:DyaK28zis1GhsQ%3D%3D 8696550
3. SF Sener A Fremgen HR Menck, et al. 1999 Pancreatic cancer: a report of treatment and survival trends for 100, 313 patients diagnosed from 1985-1995, using the National Cancer Database J Am Coll Surg 189 1 7 10.1016/S1072-7515(99) 00075-7 1:STN:280:DyaK1MzivVWlsg%3D%3D 10401733 (Pubitemid 29307735)
4. Y Murakami K Uemura T Sasaki, et al. 2005 Long-term survival of pancreatic cancer patient diagnosed by positive telomerase activity of pancreatic juice Surgery 138 962 963 10.1016/j.surg.2005.07.031 16291404 (Pubitemid 41608497)
5. Y Murakami K Uemura T Sudo, et al. 2008 Postoperative adjuvant chemotherapy improves survival after surgical resection for pancreatic carcinoma J Gastrointest Surg 12 534 541 10.1007/s11605-007-0407-5 18026816
6. JM Winter JL Cameron KA Campbell, et al. 2006 1423 Pancreaticoduodenectomies for pancreatic cancer: a single-institution experience J Gastrointest Surg 10 1199 1211 10.1016/j.gassur.2006.08.018 17114007 (Pubitemid 44781200)
7. HJ Moon JY An JS Heo, et al. 2006 Predicting survival after surgical resection for pancreatic ductal adenocarcinoma Pancreas 32 37 43 10.1097/01.mpa.0000194609.24606.4b 16340742
8. M Wagner C Redaelli M Lietz, et al. 2004 Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma Br J Surg 91 586 594 10.1002/bjs.4484 1:STN:280: DC%2BD2c3it1ansA%3D%3D 15122610 (Pubitemid 38624667)
9. KF Kuhlmann SM de Castro JG Wesseling, et al. 2004 Surgical treatment of pancreatic adenocarcinoma; actual survival and prognostic factors in 343 patients Eur J Cancer 40 549 558 10.1016/j.ejca.2003.10.026 1:STN:280: DC%2BD2c%2FntlKgsw%3D%3D 14962722 (Pubitemid 38220772)
10. S Matsuno S Egawa S Fukuyama, et al. 2004 Pancreatic Cancer Registry in Japan: 20 years of experience Pancreas 28 219 230 10.1097/00006676-200404000- 00002 15084961 (Pubitemid 38437313)
11. AC Berger IM Meszoely EA Ross, et al. 2004 Undetectable preoperative levels of serum CA 19-9 correlate with improved survival for patients with resectable pancreatic adenocarcinoma Ann Surg Oncol 11 644 649 10.1245/ASO.2004.11.025 15197014 (Pubitemid 40486698)
12. A Richter M Niedergethmann JW Sturm, et al. 2003 Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience World J Surg 27 324 329 10.1007/s00268-002-6659-z 12607060 (Pubitemid 36920145)
13. FA Wenger F Peter J Zieren, et al. 2000 Prognosis factors in carcinoma of the head of the pancreas Dig Surg 17 29 35 10.1159/000018797 1:STN:280:DC%2BD3c7ovVSrsg%3D%3D 10720829
14. TA Sohn CJ Yeo JL Cameron, et al. 2000 Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators J Gastrointest Surg 4 567 579 10.1016/S1091-255X(00)80105-5 1:STN:280: DC%2BD3Mzlt1yqtA%3D%3D 11307091
15. T Nagakawa H Kobayashi K Ueno, et al. 1994 Clinical study of lymphatic flow to the paraaortic lymph nodes in carcinoma of the head of the pancreas Cancer 73 1155 1162 10.1002/1097-0142(19940215)73:4<1155::AID- CNCR2820730406>3.0.CO;2-H 1:STN:280:DyaK2c7kslegtg%3D%3D 8313317
16. M Kayahara T Nagakawa T Ohta, et al. 1999 Analysis of paraaortic lymph node involvement in pancreatic carcinoma: a significant indication for surgery? Cancer 85 583 590 10.1002/(SICI)1097-0142(19990201)85:3<583::AID-CNCR8>3. 0.CO;2-J 1:STN:280:DyaK1M7ptVWmsA%3D%3D 10091731 (Pubitemid 29075279)
17. T Yoshida T Matsumoto A Sasaki, et al. 2004 Outcome of paraaortic node-positive pancreatic head and bile duct adenocarcinoma Am J Surg 187 736 740 10.1016/j.amjsurg.2003.07.031 15191867 (Pubitemid 38748859)
18. M Sakai A Nakao T Kaneko, et al. 2005 Para-aortic lymph node metastasis in carcinoma of the head of the pancreas Surgery 137 606 611 10.1016/j.surg.2005.02.009 15933626 (Pubitemid 40755416)
19. K Shimada Y Sakamoto T Sano, et al. 2006 The role of paraaortic lymph node involvement on early recurrence and survival after macroscopic curative resection with extended lymphadenectomy for pancreatic carcinoma J Am Coll Surg 203 345 352 10.1016/j.jamcollsurg.2006.05.289 16931307 (Pubitemid 44247756)
20. R Doi K Kami D Ito, et al. 2007 Prognostic implication of para-aortic lymph node metastasis in resectable pancreatic cancer World J Surg 31 147 154 10.1007/s00268-005-0730-5 17171496 (Pubitemid 46091587)
21. Y Murakami K Uemura H Ohge, et al. 2006 Intraductal papillary-mucinous neoplasms and mucinous cystic neoplasms of the pancreas differentiated by ovarian-type stroma Surgery 140 448 453 10.1016/j.surg.2006.03.017 16934608
22. Y Murakami K Uemura Y Hayashidani, et al. 2007 Predictive factors of malignant or invasive intraductal papillary-mucinous neoplasms of the pancreas J Gastrointest Surg 11 338 344 10.1007/s11605-006-0069-8 17458608
23. International Union Against Cancer (UICC) (2002) TNM classification of malignant tumors, vol 6. Wiley-Liss, New York
24. Y Murakami K Uemura T Sudo, et al. 2008 Adjuvant gemcitabine plus S-1 chemotherapy after surgical resection for pancreatic adenocarcinoma Am J Surg 195 757 762 10.1016/j.amjsurg.2007.04.018 1:CAS:528:DC%2BD1cXmsFKqtrg%3D 18367131 (Pubitemid 351749450)
25. H Oettle S Post P Neuhaus, et al. 2007 Adjuvant chemotherapy with gemcitabine vs. observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial JAMA 297 267 277 10.1001/jama.297.3.267 1:CAS:528:DC%2BD2sXotVCmug%3D%3D 17227978 (Pubitemid 46143304)
26. K Nakamura T Yamaguchi T Ishihara, et al. 2006 Phase II trial of oral S-1 combined with gemcitabine in metastatic pancreatic cancer Br J Cancer 94 1575 1579 1:CAS:528:DC%2BD28XltVOmurs%3D 16721372
27. Y Murakami K Uemura T Sudo, et al. 2009 Impact of adjuvant gemcitabine plus S-1 chemotherapy after surgical resection for adenocarcinoma of the body or tail of the pancreas J Gastrointest Surg 13 85 92 10.1007/s11605-008-0650-4 18704593
28. S Connor L Bosonnet P Ghaneh, et al. 2004 Survival of patients with periampullary carcinoma is predicted by lymph node 8a but not by lymph node 16b1 status Br J Surg 91 1592 1599 10.1002/bjs.4761 1:STN:280:DC%2BD2cngt12ntA%3D%3D 15515111 (Pubitemid 39619923)
29. H Riediger T Keck U Wellner, et al. 2004 The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer J Gastrointest Surg 13 1337 1344 10.1007/s11605-009-0919-2
30. P Massucco D Ribero E Sgotto, et al. 2009 Prognostic significance of lymph node metastases in pancreatic head cancer treated with extended lymphadenectomy: not just a matter of numbers Ann Surg Oncol 16 3323 3332 10.1245/s10434-009-0672-5 19777195